Coming December: ASH publishes its late-breaking abstracts. We’ll add the organizations presenting them.

University of Southern California at ASH 2026

Dec 12–15, 2026 New Orleans, LA ~30k attendees Website

University of Southern California brings 4 presentations to ASH 2026 in New Orleans. Its program spans rare blood conditions, CAR-T and hemophilia costs. Work covers dual BCMA and GPRC5D in vivo CAR-T, an expert consensus on cold agglutinin disease and marstacimab costs.

OrganizationASH 2026 Attendance
Universities & research institutes
Private research university in Los Angeles with the Keck School of Medicine and the Norris cancer center.
Symposium
Fri Dec 11
3:00pm–6:00pm
Acknowledging the Rare: Navigating Diagnostic and Therapeutic Complexities in Rare Hematologic Disorders
Speeding diagnosis and easing treatment burden in idiopathic multicentric Castleman disease, cold agglutinin disease, and immune thrombocytopenia.
Patient care

Explore the full ASH 2026 dataset

Get in-depth attendee and institution profiles and research, to plan your meetings in New Orleans. Leave your work email and we’ll be in touch.

Privacy

Download the full ASH 2026 CSV

Leave your work email and we’ll be in touch. The CSV adds attendee names, roles and contact details to the company and session data shown here.

Privacy

Find decision makers at University of Southern California

Tell us what you sell and we’ll find the people at University of Southern California most likely to buy it.

  • Who to contact
  • Their contact info
  • What to say
  • Free, no sign-up

Not affiliated with or endorsed by the American Society of Hematology (ASH). Submit a correction